Literature DB >> 20489084

Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.

Chan Kyo Kim1, Byung Kwan Park, Bohyun Kim.   

Abstract

OBJECTIVE: The objective of this article is to review the basic concepts for the biologic basis of diffusion-weighted MRI (DWI), illustrate its potential clinical applications at 3 T, and discuss its current limitations and future directions.
CONCLUSION: The increased signal-to-noise ratio of DWI provided by 3 T compared with 1.5 T may improve tumor detection and staging, determination of tumor aggressiveness, and posttreatment follow-up. Additionally, DWI may be a useful tool to monitor therapeutic effects and guide targeted biopsies, particularly in patients with previously negative biopsy results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20489084     DOI: 10.2214/AJR.09.3654

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  37 in total

1.  Prostate cancer: predicting tumor aggressiveness using DWI-guided biopsy.

Authors:  Chan Kyo Kim; Satoru Takahashi
Journal:  Nat Rev Urol       Date:  2011-10-25       Impact factor: 14.432

2.  Diffusion-weighted MRI of the prostate: advantages of Zoomed EPI with parallel-transmit-accelerated 2D-selective excitation imaging.

Authors:  Kolja M Thierfelder; Michael K Scherr; Mike Notohamiprodjo; Jakob Weiß; Olaf Dietrich; Ullrich G Mueller-Lisse; Josef Pfeuffer; Konstantin Nikolaou; Daniel Theisen
Journal:  Eur Radiol       Date:  2014-08-27       Impact factor: 5.315

3.  Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting.

Authors:  Yousef Mazaheri; Hebert Alberto Vargas; Oguz Akin; Debra A Goldman; Hedvig Hricak
Journal:  J Magn Reson Imaging       Date:  2011-11-08       Impact factor: 4.813

4.  Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.

Authors:  Andrew B Rosenkrantz; Hersh Chandarana; Nicole Hindman; Fang-Ming Deng; James S Babb; Samir S Taneja; Christian Geppert
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

5.  Poor standard mp-MRI and routine biopsy fail to precisely predict intraprostatic tumor localization.

Authors:  Andrea Billing; Alexander Buchner; Christian Stief; Alexander Roosen
Journal:  World J Urol       Date:  2016-02-24       Impact factor: 4.226

6.  Imaging: standardizing the use of functional MRI in prostate cancer.

Authors:  Nandita M deSouza; Evis Sala
Journal:  Nat Rev Urol       Date:  2011-02-15       Impact factor: 14.432

7.  Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice.

Authors:  Andrea Billing; Alexander Buchner; Christian Stief; Alexander Roosen
Journal:  World J Urol       Date:  2014-11-29       Impact factor: 4.226

8.  Segmented diffusion-weighted imaging of the prostate: Application to transperineal in-bore 3T MR image-guided targeted biopsy.

Authors:  Andriy Fedorov; Kemal Tuncali; Lawrence P Panych; Janice Fairhurst; Elmira Hassanzadeh; Ravi T Seethamraju; Clare M Tempany; Stephan E Maier
Journal:  Magn Reson Imaging       Date:  2016-05-27       Impact factor: 2.546

9.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

10.  Prostate diffusion-weighted imaging at 3T: effect of intravenous gadobutrol administration.

Authors:  Chan Kyo Kim; Jung Jae Park; Byung Kwan Park
Journal:  Eur Radiol       Date:  2015-08-09       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.